Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.

Alex Soriano Patrick M Honoré Oliver Andreas Cornely Methee ChayakulkeereeMatteo BassettiHaihui Huang Hervé Dupont Young Keun KimMarin KollefBart Jan Kullberg Nick ManamleyPeter PappasJohn PullmanTaylor SandisonCecilia Dignani Jose A Vazquez George R Thompson Iii

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

These findings support the efficacy and safety of rezafungin compared with caspofungin for the treatment of candidemia and/or IC in patients with a positive culture close to randomization, with potential early treatment benefits for rezafungin.

Keyphrases

risk assessment
pseudomonas aeruginosa
replacement therapy
biofilm formation
smoking cessation